None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Newly diagnosed colorectal cancer in the university hospital participating in the study, patients aged 19 and under 75. 2) patient who was undertaken follow up colonoscopywithin 5 years after index colonoscopy 3) patient who agree with particition of this study after listening to the explanation of the study Non-probability sampling method
Exclusion criteria
Exclusion criteria: 1) A history of colectomy for CRC 2) CRCs from inflammatory bowel disease 3) Familial adenomatous polyposis 4) Liver cihrrosis, CHF[NYHA grade III or IV], CRF [Ccr <30ml/min], uncontrolled hypertension, other malignant diseae and immune suppresion 5) porgnant women, lactating women 6)In case cooperation is difficult, such as communication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical and molecular chraateristuc of interval colon cancer (patient information, index colonoscopy result, pathology result, TNM stagingm, molecular biology marke( BRAF, CIMP (CpG island methylation phenotype), MSI, KRAS ?? | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference between aporadic cancr and interval cancer and etiology of interval cancer | — |
Countries
Korea, Republic of
Contacts
Konyang University Hospital